Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03063320 · ClinicalTrials.gov registry record · NA

The Effect of Spice Consumption on Postprandial Vascular Function

A NA study of Cardiovascular Risk Factor, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT03063320 is a NA study of Cardiovascular Risk Factor that has completed, run by Penn State University. The registered enrollment target is 43 participants, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03063320, a NA study of Cardiovascular Risk Factor, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

A 3-period randomized cross-over, controlled feeding study will be conducted to determine the effect of chronic spice consumption on postprandial vascular function. Participants will consume three test diets containing different amounts of spice. Each treatment period will last for 4 weeks. After each diet period a meal test will be conducted. Participants will consume a meal with a spice content corresponding to the diet period they have just completed. Endothelial function will be measured at 2 and 4 hours after meal consumption. Blood samples will also be taken during the 4 hours after meal consumption for measurement of lipids, immune and inflammatory markers.

Conditions Studied

Interventions

  • OTHER Spice blend

Study Locations (1)

Pennsylvania

  • Penn State University - University Park

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2017-01-25
Est. Completion 2020-02-26
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT03063320

The ClinicalTrials.gov registry entry for NCT03063320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,067-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (99% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 1 intervention - of which Spice blend is the first listed.

NCT03063320 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03063320 about?

NCT03063320 is a clinical study titled "The Effect of Spice Consumption on Postprandial Vascular Function". A 3-period randomized cross-over, controlled feeding study will be conducted to determine the effect of chronic spice consumption on postprandial vascular function. Participants will consume three test diets containing different amounts of spice. Each treatment period will last for 4 weeks. After ea...

What is the current status of trial NCT03063320?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-01-25. Estimated completion is 2020-02-26.

What conditions does trial NCT03063320 study?

This clinical trial studies the following conditions: Cardiovascular Risk Factor.

What interventions are being tested in trial NCT03063320?

The interventions under investigation include: Spice blend (OTHER).

Who is sponsoring clinical trial NCT03063320?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03063320 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Risk Factor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.